Top

Published in:

Open Access 01-10-2018 | Original Paper

Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients

Authors: Xin Chen, Arnaud J. Legrand, Siobhan Cunniffe, Samuel Hume, Mattia Poletto, Bruno Vaz, Kristijan Ramadan, Dengfu Yao, Grigory L. Dianov

Published in: Cellular Oncology | Issue 5/2018

Abstract

Background

To deliver efficacious personalised cancer treatment, it is essential to characterise the cellular metabolism as well as the genetic stability of individual tumours. In this study, we describe a new axis between DNA repair and detoxification of aldehyde derivatives with important implications for patient prognosis and treatment.

Methods

Western blot and qPCR analyses were performed in relevant non-transformed and cancer cell lines from lung and liver tissue origin in combination with bioinformatics data mining of The Cancer Genome Atlas database from lung and hepatocellular cancer patients.

Results

Using both biochemical and bioinformatics approaches, we revealed an association between the levels of expression of the aldehyde detoxifying enzyme aldehyde dehydrogenase 2 (ALDH2) and the key DNA base excision repair protein XRCC1. Across cancer types, we found that if one of the corresponding genes exhibits a low expression level, the level of the other gene is increased. Surprisingly, we found that low ALDH2 expression levels associated with high XRCC1 expression levels are indicative for a poor overall survival, particularly in lung and liver cancer patients. In addition, we found that Mithramycin A, a XRCC1 expression inhibitor, efficiently kills cancer cells expressing low levels of ALDH2.

Conclusions

Our data suggest that lung and liver cancers require efficient single-strand break repair for their growth in order to benefit from a low aldehyde detoxification metabolism. We also propose that the ratio of XRCC1 and ALDH2 levels may serve as a useful prognostic tool in these cancer types.

Available only for authorised users

H.K. Seitz, F. Stickel, Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7, 599–612 (2007). https://doi.org/10.1038/nrc2191 CrossRefPubMed

E.M. Tacconi, X. Lai, C. Folio, M. Porru, G. Zonderland, S. Badie, J. Michl, I. Sechi, M. Rogier, V. Matia Garcia, A.S. Batra, O.M. Rueda, P. Bouwman, J. Jonkers, A. Ryan, B. Reina-San-Martin, J. Hui, N. Tang, A. Bruna, A. Biroccio, M. Tarsounas, BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity. EMBO Mol Med. 9, 1398–1414 (2017). https://doi.org/10.15252/emmm.201607446 CrossRefPubMedPubMedCentral

P.J. O'Brien, A.G. Siraki, N. Shangari, Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 35, 609–662 (2005)CrossRefPubMed

G.P. Voulgaridou, I. Anestopoulos, R. Franco, M.I. Panayiotidis, A. Pappa, DNA damage induced by endogenous aldehydes: Current state of knowledge. Mutat Res 711, 13–27 (2011). https://doi.org/10.1016/j.mrfmmm.2011.03.006 CrossRefPubMed

C.H. Chen, J.C. Ferreira, E.R. Gross, D. Mochly-Rosen, Targeting aldehyde dehydrogenase 2: New therapeutic opportunities. Physiol Rev 94, 1–34 (2014). https://doi.org/10.1152/physrev.00017.2013 CrossRefPubMedPubMedCentral

K. Parmar, A.D. D'Andrea, Aldehydes pose a threat to BRCA2 mutation carriers. Cell 169, 979–981 (2017). https://doi.org/10.1016/j.cell.2017.05.021 CrossRefPubMed

J. Abraham, S. Balbo, D. Crabb, P.J. Brooks, Alcohol metabolism in human cells causes DNA damage and activates the Fanconi anemia-breast cancer susceptibility (FA-BRCA) DNA damage response network. Alcohol Clin Exp Res 35, 2113–2120 (2011). https://doi.org/10.1111/j.1530-0277.2011.01563.x CrossRefPubMedPubMedCentral

J.I. Garaycoechea, G.P. Crossan, F. Langevin, M. Daly, M.J. Arends, K.J. Patel, Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489, 571–575 (2012). https://doi.org/10.1038/nature11368 CrossRefPubMed

S.L.W. Tan, S. Chadha, Y. Liu, E. Gabasova, D. Perera, K. Ahmed, S. Constantinou, X. Renaudin, M. Lee, R. Aebersold, A.R. Venkitaraman, A class of environmental and endogenous toxins induces BRCA2 Haploinsufficiency and genome instability. Cell 169, 1105–1118 (2017). https://doi.org/10.1016/j.cell.2017.05.010 CrossRefPubMedPubMedCentral

10.

H.S. Yu, T. Oyama, T. Isse, K. Kitagawa, T.T. Pham, M. Tanaka, T. Kawamoto, Formation of acetaldehyde-derived DNA adducts due to alcohol exposure. Chem Biol Interact 188, 367–375 (2010). https://doi.org/10.1016/j.cbi.2010.08.005 CrossRefPubMed

11.

H. Nagayoshi, A. Matsumoto, R. Nishi, T. Kawamoto, M. Ichiba, T. Matsuda, Increased formation of gastric N(2)-ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout mice treated with ethanol. Mutat Res 673, 74–77 (2009). https://doi.org/10.1016/j.mrgentox.2008.11.009 CrossRefPubMed

12.

G.L. Dianov, U. Hubscher, Mammalian base excision repair: The forgotten archangel. Nucleic Acids Res 41, 3483–3490 (2013). https://doi.org/10.1093/nar/gkt076 CrossRefPubMedPubMedCentral

13.

G. Dianov, T. Lindahl, Reconstitution of the DNA base excision-repair pathway. Curr Biol 4, 1069–1076 (1994)CrossRefPubMed

14.

A. Klungland, T. Lindahl, Second pathway for completion of human DNA base excision-repair: Reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J 16, 3341–3348 (1997)CrossRefPubMedPubMedCentral

15.

I.I. Dianova, K.M. Sleeth, S.L. Allinson, J.L. Parsons, C. Breslin, K.W. Caldecott, G.L. Dianov, XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. Nucleic Acids Res 32, 2550–2555 (2004). https://doi.org/10.1093/nar/gkh567 CrossRefPubMedPubMedCentral

16.

K.W. Caldecott, XRCC1 and DNA strand break repair. DNA Repair 2, 955–969 (2003)CrossRefPubMed

17.

E. Markkanen, R. Fischer, M. Ledentcova, B.M. Kessler, G.L. Dianov, Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability. Nucleic Acids Res 43, 3667–3679 (2015). https://doi.org/10.1093/nar/gkv222 CrossRefPubMedPubMedCentral

18.

L.F. Stead, S. Berri, H.M. Wood, P. Egan, C. Conway, C. Daly, K. Papagiannopoulos, P. Rabbitts, The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma. Neoplasia 14, 1075–1086 (2012)CrossRefPubMedPubMedCentral

19.

G. Orlando, S.V. Khoronenkova, I.I. Dianova, J.L. Parsons, G.L. Dianov, ARF induction in response to DNA strand breaks is regulated by PARP1. Nucleic Acids Res 42, 2320–2329 (2014). https://doi.org/10.1093/nar/gkt1185 CrossRefPubMed

20.

K. Kiianitsa, N. Maizels, A rapid and sensitive assay for DNA-protein covalent complexes in living cells. Nucleic Acids Res 41, e104 (2013). https://doi.org/10.1093/nar/gkt171 CrossRefPubMedPubMedCentral

21.

A.J. Link, J. LaBaer, Trichloroacetic acid (TCA) precipitation of proteins. Cold Spring Harb Protoc 2011, 993–994 (2011). https://doi.org/10.1101/pdb.prot5651 CrossRefPubMed

22.

J. Gao, B.A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross, S.O. Sumer, Y. Sun, A. Jacobsen, R. Sinha, E. Larsson, E. Cerami, C. Sander, N. Schultz, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6, l1 (2013). https://doi.org/10.1126/scisignal.2004088 CrossRef

23.

E. Cerami, J. Gao, U. Dogrusoz, B.E. Gross, S.O. Sumer, B.A. Aksoy, A. Jacobsen, C.J. Byrne, M.L. Heuer, E. Larsson, Y. Antipin, B. Reva, A.P. Goldberg, C. Sander, N. Schultz, The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2, 401–404 (2012). https://doi.org/10.1158/2159-8290.CD-12-0095 CrossRefPubMed

24.

G. Antoniali, L. Lirussi, M. Poletto, G. Tell, Emerging roles of the nucleolus in regulating the DNA damage response: The noncanonical DNA repair enzyme APE1/Ref-1 as a paradigmatical example. Antioxid Redox Signal 20, 621–639 (2014). https://doi.org/10.1089/ars.2013.5491 CrossRefPubMedPubMedCentral

25.

M. Poletto, A.J. Legrand, S.C. Fletcher, G.L. Dianov, p53 coordinates base excision repair to prevent genomic instability. Nucleic Acids Res 44, 3165–3175 (2016). https://doi.org/10.1093/nar/gkw015 CrossRefPubMedPubMedCentral

26.

J.K. Horton, M. Watson, D.F. Stefanick, D.T. Shaughnessy, J.A. Taylor, S.H. Wilson, XRCC1 and DNA polymerase beta in cellular protection against cytotoxic DNA single-strand breaks. Cell Res 18, 48–63 (2008). https://doi.org/10.1038/cr.2008.7 CrossRefPubMedPubMedCentral

27.

B. Vaz, M. Popovic, J.A. Newman, J. Fielden, H. Aitkenhead, S. Halder, A.N. Singh, I. Vendrell, R. Fischer, I. Torrecilla, N. Drobnitzky, R. Freire, D.J. Amor, P.J. Lockhart, B.M. Kessler, G.W. McKenna, O. Gileadi, K. Ramadan, Metalloprotease SPRTN/DVC1 orchestrates replication-coupled DNA-protein crosslink repair. Mol Cell 64, 704–719 (2016). https://doi.org/10.1016/j.molcel.2016.09.032 CrossRefPubMedPubMedCentral

28.

B. Vaz, M. Popovic, K. Ramadan, DNA-protein crosslink proteolysis repair. Trends Biochem Sci 42, 483–495 (2017). https://doi.org/10.1016/j.tibs.2017.03.005 CrossRefPubMed

29.

M.J. Stewart, K. Malek, D.W. Crabb, Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J Investig Med 44, 42–46 (1996)PubMed

30.

S.C. Fletcher, C.P. Grou, A.J. Legrand, X. Chen, K. Soderstrom, M. Poletto, G.L. Dianov, Sp1 phosphorylation by ATM downregulates BER and promotes cell elimination in response to persistent DNA damage. Nucleic Acids Res 46, 1834–1846 (2018). https://doi.org/10.1093/nar/gkx1291 CrossRefPubMed

31.

D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011). https://doi.org/10.1016/j.cell.2011.02.013 CrossRef

32.

M.G. Vander Heiden, R.J. DeBerardinis, Understanding the intersections between metabolism and Cancer biology. Cell 168, 657–669 (2017). https://doi.org/10.1016/j.cell.2016.12.039 CrossRefPubMed

33.

L.B. Sullivan, D.Y. Gui, M.G.V. Heiden, Altered metabolite levels in cancer: Implications for tumour biology and cancer therapy. Nat Rev Cancer 16, 680–693 (2016). https://doi.org/10.1038/nrc.2016.85 CrossRefPubMed

34.

A.J. Legrand, M. Poletto, D. Pankova, E. Clementi, J. Moore, F. Castro-Giner, A.J. Ryan, E. O'Neill, E. Markkanen, G.L. Dianov, Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts. Oncotarget 9, 13666–13681 (2018). https://doi.org/10.18632/oncotarget.24446 CrossRefPubMedPubMedCentral

35.

G. Burgos-Barragan, N. Wit, J. Meiser, F.A. Dingler, M. Pietzke, L. Mulderrig, L.B. Pontel, I.V. Rosado, T.F. Brewer, R.L. Cordell, P.S. Monks, C.J. Chang, A. Vazquez, K.J. Patel, Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism. Nature 548, 549–554 (2017). https://doi.org/10.1038/nature23481 CrossRefPubMedPubMedCentral

36.

M.J. Nokin, F. Durieux, P. Peixoto, B. Chiavarina, O. Peulen, A. Blomme, A. Turtoi, B. Costanza, N. Smargiasso, D. Baiwir, J.L. Scheijen, C.G. Schalkwijk, J. Leenders, P. De Tullio, E. Bianchi, M. Thiry, K. Uchida, D.A. Spiegel, J.R. Cochrane, C.A. Hutton, E. De Pauw, P. Delvenne, D. Belpomme, V. Castronovo, A. Bellahcene, Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis. elife 5 (2016). https://doi.org/10.7554/eLife.19375

37.

D.E. Maessen, C.D. Stehouwer, C.G. Schalkwijk, The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci 128, 839–861 (2015). https://doi.org/10.1042/CS20140683 CrossRefPubMed

38.

D. Lessel, B. Vaz, S. Halder, P.J. Lockhart, I. Marinovic-Terzic, J. Lopez-Mosqueda, M. Philipp, J.C. Sim, K.R. Smith, J. Oehler, E. Cabrera, R. Freire, K. Pope, A. Nahid, F. Norris, R.J. Leventer, M.B. Delatycki, G. Barbi, S. von Ameln, J. Hogel, M. Degoricija, R. Fertig, M.D. Burkhalter, K. Hofmann, H. Thiele, J. Altmuller, G. Nurnberg, P. Nurnberg, M. Bahlo, G.M. Martin, C.M. Aalfs, J. Oshima, J. Terzic, D.J. Amor, I. Dikic, K. Ramadan, C. Kubisch, Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat Genet 46, 1239–1244 (2014). https://doi.org/10.1038/ng.3103 CrossRefPubMedPubMedCentral

39.

R.A. Sharma, G.L. Dianov, Targeting base excision repair to improve cancer therapies. Mol Asp Med 28, 345–374 (2007). https://doi.org/10.1016/j.mam.2007.06.002 CrossRef

40.

A. Kothandapani, A. Sawant, V.S. Dangeti, R.W. Sobol, S.M. Patrick, Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity. Nucleic Acids Res 41, 7332–7343 (2013). https://doi.org/10.1093/nar/gkt479 CrossRefPubMedPubMedCentral

41.

A. Kothandapani, S.M. Patrick, Evidence for base excision repair processing of DNA interstrand crosslinks. Mutat Res 743-744, 44–52 (2013). https://doi.org/10.1016/j.mrfmmm.2012.11.007 CrossRefPubMed

42.

B.B. Das, S.Y. Huang, J. Murai, I. Rehman, J.C. Ame, S. Sengupta, S.K. Das, P. Majumdar, H. Zhang, D. Biard, H.K. Majumder, V. Schreiber, Y. Pommier, PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage. Nucleic Acids Res 42, 4435–4449 (2014). https://doi.org/10.1093/nar/gku088 CrossRefPubMedPubMedCentral

43.

B.J. Kennedy, Metabolic and toxic effects of mithramycin during tumor therapy. Am J Med 49, 494–503 (1970)CrossRefPubMed

44.

L.E. Nunez, S.E. Nybo, J. Gonzalez-Sabin, M. Perez, N. Menendez, A.F. Brana, K.A. Shaaban, M. He, F. Moris, J.A. Salas, J. Rohr, C. Mendez, A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis. J Med Chem 55, 5813–5825 (2012). https://doi.org/10.1021/jm300234t CrossRefPubMedPubMedCentral

45.

A. Malek, L.E. Nunez, M. Magistri, L. Brambilla, S. Jovic, G.M. Carbone, F. Moris, C.V. Catapano, Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer. PLoS One 7, e35130 (2012). https://doi.org/10.1371/journal.pone.0035130 CrossRefPubMedPubMedCentral

46.

M. Poletto, A.J. Legrand, G.L. Dianov, DNA Base excision repair: The Achilles' heel of tumour cells and their microenvironment? Curr Pharm Des 23, 4758–4772 (2017). https://doi.org/10.2174/1381612823666170710123602 CrossRefPubMed

Title: Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients
Authors: Xin Chen
Arnaud J. Legrand
Siobhan Cunniffe
Samuel Hume
Mattia Poletto
Bruno Vaz
Kristijan Ramadan
Dengfu Yao
Grigory L. Dianov
Publication date: 01-10-2018
Publisher: Springer Netherlands
Published in: Cellular Oncology / Issue 5/2018
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI: https://doi.org/10.1007/s13402-018-0390-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2018

Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation

TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms

Correction to: β-Catenin gene promoter hypermethylation by reactive oxygen species correlates with the migratory and invasive potentials of colon cancer cells

β-Catenin gene promoter hypermethylation by reactive oxygen species correlates with the migratory and invasive potentials of colon cancer cells

Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk

Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer